Search

Margrit Schwarz

from Stow, MA
Age ~60
Get Report
Also known as:
Margart Schwarz
Related to:
Richard A Damore, 70Michael S Hennessy, 52Mark S Damore, 43
Connected to:
Adrienne L Schwarz, 53Alana M Schwarz, 42Alicia R Schwarz, 47Alison R Schwarzwalder, 49Alissa J Schwarz, 41Allan B Schwarz, 63Alvin D Schwarz, 86Andrew B Schwarze, 37Ann C Schwarz, 83Anna R Schwarzbach, 36

Margrit Schwarz Phones & Addresses

  • Stow, MA
  • 1630 Hull Dr, San Carlos, CA 94070
  • Redwood City, CA
  • Danbury, CT
  • Mountain View, CA
  • San Francisco, CA
  • Foster City, CA
  • Dallas, TX
  • Richardson, TX

Work

Company: Margrit schwarz consulting llc Feb 2013 Address: San Carlos, CA Position: Independent consultant

Education

Degree: MBA School / High School: Columbia University - Columbia Business School 2009 to 2010 Specialities: Business

Languages

German • Spanish • French • Romanian

Interests

Fine art photography

Industries

Biotechnology

Resumes

Resumes

Margrit Schwarz Photo 1

Life Science Professional

View page
Position:
Independent Consultant at Margrit Schwarz Consulting LLC, Expert / Ad Hoc Advisor at EU Research Commission, Directorate Research & Innovation
Location:
San Francisco Bay Area
Industry:
Biotechnology
Work:
Margrit Schwarz Consulting LLC - San Carlos, CA since Feb 2013
Independent Consultant
EU Research Commission, Directorate Research & Innovation - Brussels Area, Belgium since Oct 2012
Expert / Ad Hoc Advisor
Amgen - Amgen South San Francisco Mar 2009 - Sep 2012
Director Research
Amgen - Amgen South San Francisco Aug 2005 - Feb 2009
Principal Scientist
Hoffmann-La Roche Basel Jul 2003 - Jul 2005
Senior Scientist
Education:
Columbia University - Columbia Business School 2009 - 2010
MBA, Business University of California, Berkeley - Walter A. Haas School of Business 2009 - 2010
MBA, Business Universität zu Köln 1990 - 1994
Ph.D., Biochemistry Westfälische Wilhelms-Universität Münster 1984 - 1990
Diploma, Chemistry
Interests:
Fine art photography
Languages:
German
Spanish
French
Romanian

Publications

Us Patents

Modified Lecithin-Cholesterol Acyltransferase Enzymes

View page
US Patent:
8168416, May 1, 2012
Filed:
Jul 25, 2008
Appl. No.:
12/179815
Inventors:
Tom Boone - Newbury Park CA, US
David Park Meininger - Seattle WA, US
Margrit Schwarz - San Carlos CA, US
Bei Shan - Redwood City CA, US
Wenyan Shen - Wayne PA, US
Mingyue Zhou - Hayward CA, US
Assignee:
Amgen Inc. - Thousand Oaks CA
International Classification:
C12N 9/10
A61K 38/45
A61P 9/00
C12P 21/02
US Classification:
435193, 514 19, 514 74, 435 691
Abstract:
The invention provides compounds, pharmaceutical compositions and methods for treating atherosclerosis, coronary heart disease, thrombosis, and for decreasing or prevention of accumulation of cholesterol in a subject by modifying LCAT polypeptide.

Substituted Biphenyl Gpr40 Modulators

View page
US Patent:
20090137561, May 28, 2009
Filed:
Oct 3, 2008
Appl. No.:
12/287036
Inventors:
Sean P. Brown - San Francisco CA, US
Qiong Cao - Daly City CA, US
Paul John Dransfield - San Francisco CA, US
Xiaohui Du - Belmont CA, US
Jonathan Houze - San Mateo CA, US
Xian Yun Jiao - Belmont CA, US
Yong-Jae Kim - Foster City CA, US
Todd J. Kohn - San Mateo CA, US
SuJen Lai - Burlingame CA, US
Daniel Lin - Redwood City CA, US
Jian Luo - Albany CA, US
Julio C. Medina - San Carlos CA, US
Jeffrey D. Reagan - Millbrae CA, US
Vatee Pattaropong - Burlingame CA, US
Margrit Schwarz - San Carlos CA, US
Wang Shen - San Mateo CA, US
Yongli Su - Foster City CA, US
Gayathri Swaminath - Fremont CA, US
Marc Vimolratana - San Mateo CA, US
Xiang Wang - Moorpark CA, US
Yumei Xiong - San Bruno CA, US
Li Yang - San Francisco CA, US
Ming Yu - Foster City CA, US
Jie Zhang - Sunnyvale CA, US
Liusheng Zhu - Foster City CA, US
Assignee:
Amgen Inc. - Thousand Oaks CA
International Classification:
C07C 59/48
A61K 31/192
A61K 31/235
C07C 69/76
C07D 309/00
A61K 31/351
C07D 211/20
A61K 31/445
A61K 31/44
A61K 31/55
C07D 223/04
A61P 7/00
US Classification:
51421712, 562469, 514568, 514543, 560102, 549416, 514460, 546248, 514317, 514345, 540610
Abstract:
The present invention provides compounds useful, for example, for treating metabolic disorders in a subject. Such compounds have the general formula I:where the definitions of the variables are provided herein. The present invention also provides compositions that include, and methods for using, the compounds in preparing medicaments and for treating metabolic disorders such as, for example, type II diabetes.

Conjugates And Methods For Treating Liver Fibrosis

View page
US Patent:
20220387600, Dec 8, 2022
Filed:
Dec 7, 2020
Appl. No.:
17/782901
Inventors:
- Basel, CH
Richard J. HOLLAND - Vancouver, CA
Mark WOOD - Moody, CA
Alan D. MARTIN - Vancouver, CA
Christine ESAU - Vancouver, CA
Margrit SCHWARZ - Stow MA, US
Xin YE - Richmond, CA
Alice Hoy Lam LI - Burnaby, CA
Christopher Justin PASETKA - Langley, CA
David CROWE - Vancouver, CA
Steven TYLER - Vancouver, CA
Assignee:
GENEVANT SCIENCES GMBH - Basel
International Classification:
A61K 47/54
C12N 15/113
Abstract:
Provided herein are certain nucleic acids (e.g., double stranded siRNA molecules), as well as conjugates that comprise a targeting moiety, a double stranded siRNA, and optional linking groups. Certain embodiments also provide synthetic methods useful for preparing the conjugates. The conjugates are useful to treat certain diseases, such as liver fibrosis, e.g., in the setting of NASH or ASH.

Conjugates And Methods For Treating Acromegaly

View page
US Patent:
20220288214, Sep 15, 2022
Filed:
Oct 23, 2020
Appl. No.:
17/770504
Inventors:
- Basel, CH
James HEYES - Vancouver, CA
Richard J. HOLLAND - Vancouver, CA
Christine ESAU - Vancouver, CA
Kevin MCCLINTOCK - Vancouver, CA
Christopher Justin PASETKA - Langley, CA
Mark WOOD - Moody, CA
Alan D. MARTIN - Vancouver, CA
Margrit SCHWARZ - Stow MA, US
David CROWE - Vancouver, CA
Steven TYLER - Vancouver, CA
Assignee:
GENEVANT SCIENCES GMBH - Basel
International Classification:
A61K 47/54
A61P 5/08
C12N 15/113
Abstract:
Provided herein are certain nucleic acids (e.g., double stranded siRNA molecules), as well as conjugates that comprise a targeting moiety, a double stranded siRNA, and optional linking groups. Certain embodiments also provide synthetic methods useful for preparing the conjugates. He conjugates are useful to treat certain diseases, such as acromegaly.

Modified Lecithin-Cholesterol Acyltransferase Enzymes

View page
US Patent:
20140287479, Sep 25, 2014
Filed:
Mar 4, 2014
Appl. No.:
14/196827
Inventors:
- Thousand Oaks CA, US
Wenyan Shen - Thousand Oaks CA, US
Bei Shan - Redwood City CA, US
Margrit Schwarz - San Carlos CA, US
David Park Meininger - Seattle WA, US
Tom Boone - Newbury Park CA, US
Assignee:
Amgen Inc. - Thousand Oaks CA
International Classification:
C12N 9/10
A61K 47/48
US Classification:
435193, 536 232
Abstract:
The invention provides compounds, pharmaceutical compositions and methods for treating atherosclerosis, coronary heart disease, thrombosis, and for decreasing or prevention of accumulation of cholesterol in a subject by modifying LCAT polypeptide.
Control profile
Margrit Schwarz from Stow, MA, age ~60 Get Report